Search results for

Food and Drug Commissioner Scott Gottlieb says he wants to know why drugmakers churn out medicines for some rare diseases but not others.

Food and Drug Commissioner Scott Gottlieb says he wants to know why drugmakers churn out medicines for some rare diseases but not others.

With unemployment down, companies are experiencing a shortage of workers. Some are offering a new array of incentives beyond higher pay to lure employees.

A 7-year trial in Mali provided house calls and health care at no charge for pregnant women and young children. The results inspired the president to make a bold pronouncement.

A 56-year-old woman who had traveled to Spain and the Netherlands for work late last year has tested positive for the coronavirus. It's New Zealand's first probable community transmission in months.

The former vice president is calling for broad reforms to policing and criminal justice in the wake of George Floyd's killing. Progressives are cautiously optimistic, but want to see more.

Without federal tracking, no one knows how many people in disability group housing have fallen ill or died from the virus. And few states are prioritizing them for vaccination.

The first gene therapy for hemophilia could be approved by the FDA within six months, according to the drugmaker, raising hopes among families. But the drug's price could be $3 million per patient.

Without federal tracking, no one knows how many people in disability group housing have fallen ill or died from the virus. And few states are prioritizing them for vaccination.

On Tuesday evening, a man opened fire on the famous market in Strasbourg, France, killing two people and leaving a third brain-dead. Hundreds of law enforcement officers are searching for the suspect.